Analyst Ratings for BioAge Labs Inc (BIOA)
BIOA Rating Summary
BIOA Price Target Summary
- Highest: $73.00 (Piper Sandler)
- Lowest: $8.00 (UBS)
- Average: $40.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$40.33 (+690.8%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
Rating Score: 6.9 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | UBS | Alice Nettleton | New Coverage | Neutral (N/A) |
8.00 (N/A) |
6.21 (5.10) |
-17.87% | Details |
| 5/27/2026 | Roth/MKM | Adam Walsh | New Coverage | Buy (N/A) |
36.00 (N/A) |
16.61 (5.10) |
-69.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
